SE8704747L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8704747L
SE8704747L SE8704747A SE8704747A SE8704747L SE 8704747 L SE8704747 L SE 8704747L SE 8704747 A SE8704747 A SE 8704747A SE 8704747 A SE8704747 A SE 8704747A SE 8704747 L SE8704747 L SE 8704747L
Authority
SE
Sweden
Prior art keywords
sub
sup
alkyl
cycloalkyl
phenyl
Prior art date
Application number
SE8704747A
Other languages
English (en)
Other versions
SE8704747D0 (sv
Inventor
M B Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40347948&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8704747(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8704747D0 publication Critical patent/SE8704747D0/sv
Publication of SE8704747L publication Critical patent/SE8704747L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8704747A 1985-06-25 1987-11-27 Farmaceutisk komposition SE8704747L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858516083A GB8516083D0 (en) 1985-06-25 1985-06-25 Heterocyclic compounds
GB868628474A GB8628474D0 (en) 1985-06-25 1986-11-28 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE8704747D0 SE8704747D0 (sv) 1987-11-27
SE8704747L true SE8704747L (sv) 1988-05-29

Family

ID=40347948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704747A SE8704747L (sv) 1985-06-25 1987-11-27 Farmaceutisk komposition

Country Status (22)

Country Link
US (2) US4753789A (sv)
EP (2) EP0226266B1 (sv)
JP (2) JPS6253920A (sv)
AT (2) ATE134510T1 (sv)
AU (2) AU609028B2 (sv)
BE (1) BE1002249A4 (sv)
CA (1) CA1296637C (sv)
CH (1) CH672068A5 (sv)
CY (1) CY2000A (sv)
DE (2) DE3650488T2 (sv)
DK (1) DK624687A (sv)
FR (1) FR2613934B1 (sv)
GB (3) GB8516083D0 (sv)
HK (1) HK82597A (sv)
IE (1) IE60908B1 (sv)
IL (1) IL84638A (sv)
IT (1) IT1211937B (sv)
NL (1) NL8702853A (sv)
NZ (1) NZ222743A (sv)
SE (1) SE8704747L (sv)
SG (1) SG43311A1 (sv)
ZA (1) ZA878927B (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
NZ222950A (en) * 1986-12-17 1997-06-24 Glaxo Group Ltd Use of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl] -4h- carbazol-4-one for the manufacture of medicaments
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
JPH0754759B2 (ja) * 1987-04-27 1995-06-07 日本電信電話株式会社 プラズマ処理方法および装置並びにプラズマ処理装置用モード変換器
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
GB8806224D0 (en) * 1988-03-16 1988-04-13 Johnson Matthey Plc Platinum chemotherapeutic product
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5039528A (en) * 1989-12-11 1991-08-13 Olney John W EAA antagonists as anti-emetic drugs
US4971651A (en) * 1990-02-05 1990-11-20 Hitachi, Ltd. Microwave plasma processing method and apparatus
EP0591395A1 (en) * 1991-06-26 1994-04-13 Sepracor, Inc. Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
WO1993000074A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
ES2149767T5 (es) * 1991-09-20 2005-06-16 Glaxo Group Limited Nuevo uso medico para antagonistas de taquiquininas.
KR960700711A (ko) * 1993-03-08 1996-02-24 후지야마 아키라 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases)
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
EP1181015A2 (en) 1999-03-01 2002-02-27 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
KR100434390B1 (ko) * 2001-04-20 2004-06-04 안국약품 주식회사 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온을 유효성분으로 하는 비강분무용조성물
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
NZ541009A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating nausea, vomiting, retching or any combination thereof
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
MY143789A (en) * 2003-02-18 2011-07-15 Helsinn Healthcare Sa Use of palonosetron treating post- operative nausea and vomiting
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20060167072A1 (en) * 2004-01-30 2006-07-27 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
WO2005108392A2 (en) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
UA97653C2 (ru) * 2006-10-24 2012-03-12 Хелсинн Хелткер С.А. Мягкие капсулы, содержащие палоносетрона гидрохлорид, которые имеют улучшенную стабильность и биологическую доступность
JP2010050046A (ja) 2008-08-25 2010-03-04 Hitachi High-Technologies Corp プラズマ処理装置
US20110160264A1 (en) 2009-12-28 2011-06-30 Monosol Rx, Llc Orally administrable film dosage forms containing ondansetron
MX342993B (es) 2013-04-25 2016-10-13 Inst Mexicano Del Petróleo Proceso de obtencion de copolimeros aleatorios derivados del acido itaconico y/o sus isomeros y alquenil sulfonatos de sodio y uso del producto obtenido.
WO2018129434A1 (en) 2017-01-09 2018-07-12 Gt Biopharma, Inc. Use and composition for treating myasthenia gravis and other myasthenic syndromes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
BE894285A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
IE57809B1 (en) * 1984-01-25 1993-04-21 Glaxo Group Ltd 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
DK624687A (da) 1988-05-29
GB8516083D0 (en) 1985-07-31
ZA878927B (en) 1988-10-26
AU616386B2 (en) 1991-10-31
AU6703786A (en) 1988-06-30
IT8748643A0 (it) 1987-11-27
CA1296637C (en) 1992-03-03
ATA312587A (de) 1992-05-15
NZ222743A (en) 1991-09-25
EP0431443A2 (en) 1991-06-12
EP0431443A3 (en) 1991-09-18
AU609028B2 (en) 1991-04-26
US4753789A (en) 1988-06-28
NL8702853A (nl) 1988-06-16
ATE134510T1 (de) 1996-03-15
IT1211937B (it) 1989-11-08
EP0226266A2 (en) 1987-06-24
DE3650488T2 (de) 1996-09-05
DK624687D0 (da) 1987-11-27
AU8191487A (en) 1988-06-02
HK82597A (en) 1997-06-27
IE873230L (en) 1988-05-28
GB2200046B (en) 1990-09-26
US4929632A (en) 1990-05-29
CY2000A (en) 1997-12-05
IL84638A (en) 1992-05-25
IE60908B1 (en) 1994-08-24
FR2613934A1 (fr) 1988-10-21
FR2613934B1 (fr) 1993-07-09
CH672068A5 (sv) 1989-10-31
JPS6253920A (ja) 1987-03-09
SG43311A1 (en) 1997-10-17
BE1002249A4 (fr) 1990-11-06
SE8704747D0 (sv) 1987-11-27
EP0226266B1 (en) 1996-02-28
GB8628474D0 (en) 1987-01-07
EP0226266A3 (en) 1990-01-24
GB8727836D0 (en) 1987-12-31
JPH0324447B2 (sv) 1991-04-03
JPS63198623A (ja) 1988-08-17
DE3740351A1 (de) 1988-06-09
GB2200046A (en) 1988-07-27
AT395374B (de) 1992-12-10
DE3650488D1 (de) 1996-04-04

Similar Documents

Publication Publication Date Title
SE8704747L (sv) Farmaceutisk komposition
ES8105292A1 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
ES530242A0 (es) Un procedimiento para preparar sales de un derivado de imidazol
ES8506615A1 (es) Un procedimiento para la preparacion de carboxamidas
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
EP0563127B1 (en) Improved treatment method for cancer
EP0271013A3 (en) Basic substituted phenyl acetonitriles, their preparation and medicaments containing them
IL70253A0 (en) Nitrosourea derivatives,their preparation and pharmaceutical compositions containing them
NZ227082A (en) N-(23-vinblastinoyl) derivatives of 1-aminomethyl-phosphonic acid; process for their preparation; and pharmaceutical compositions containing them
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat
KR920006277A (ko) 칼슘 흡수 억제제
ATE95180T1 (de) Berbanderivate und ihre herstellung und pharmazeutische zubereitung.
EP0204172A3 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use
ES487971A1 (es) Procedimiento para la preparacion de nuevos derivados de p-cloroacetofenona oxima con actividad analgesica
ES8407057A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ES8504701A1 (es) Procedimiento para preparar derivados de 3-aril-3-pirrolina
KR890003678A (ko) 부정맥 치료제

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8704747-8

Effective date: 19921216